AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Amalgamated Bank

Amalgamated Bank reduced its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 4.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,392 shares of the company’s stock after selling 1,218 shares during the period. Amalgamated Bank’s holdings in AdaptHealth were worth $244,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in AdaptHealth by 8.9% during the first quarter. Vanguard Group Inc. now owns 10,017,722 shares of the company’s stock valued at $115,304,000 after purchasing an additional 818,241 shares during the last quarter. Reinhart Partners LLC. grew its position in shares of AdaptHealth by 1.4% during the 2nd quarter. Reinhart Partners LLC. now owns 4,269,303 shares of the company’s stock valued at $42,693,000 after buying an additional 59,092 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in AdaptHealth by 43.9% during the second quarter. Dimensional Fund Advisors LP now owns 2,327,738 shares of the company’s stock worth $23,277,000 after acquiring an additional 710,131 shares during the period. Bank of New York Mellon Corp lifted its holdings in AdaptHealth by 2.8% in the second quarter. Bank of New York Mellon Corp now owns 746,211 shares of the company’s stock worth $7,462,000 after acquiring an additional 20,599 shares during the last quarter. Finally, First Eagle Investment Management LLC lifted its holdings in AdaptHealth by 18.2% in the first quarter. First Eagle Investment Management LLC now owns 594,951 shares of the company’s stock worth $6,848,000 after acquiring an additional 91,772 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Up 0.9 %

AHCO stock opened at $11.23 on Tuesday. The stock has a market cap of $1.50 billion, a PE ratio of -2.13, a price-to-earnings-growth ratio of 1.73 and a beta of 1.10. The firm’s 50-day simple moving average is $10.73 and its 200 day simple moving average is $10.44. AdaptHealth Corp. has a fifty-two week low of $6.37 and a fifty-two week high of $11.90. The company has a quick ratio of 0.94, a current ratio of 1.15 and a debt-to-equity ratio of 1.38.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06). The firm had revenue of $805.98 million during the quarter, compared to analyst estimates of $802.62 million. AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. AdaptHealth’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.16 EPS. As a group, sell-side analysts predict that AdaptHealth Corp. will post 0.87 EPS for the current year.

Insiders Place Their Bets

In other news, Director David Solomon Williams III sold 4,000 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $11.26, for a total transaction of $45,040.00. Following the transaction, the director now directly owns 36,899 shares of the company’s stock, valued at $415,482.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director David Solomon Williams III sold 4,000 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total value of $45,040.00. Following the completion of the transaction, the director now directly owns 36,899 shares in the company, valued at $415,482.74. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Shaw Rietkerk sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total value of $281,000.00. Following the sale, the chief operating officer now directly owns 212,611 shares in the company, valued at approximately $2,389,747.64. The disclosure for this sale can be found here. 4.43% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reaffirmed an “outperform” rating and set a $13.00 target price on shares of AdaptHealth in a report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.70.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.